Custom service

Cyclic Peptide Modeling

Model cyclic peptide conformation and target binding computationally

Turnaround: 2–5 weeksTypical scale: 1 – 200 mg cyclic peptideChemistry options: conformational ensemble sampling; docking with macrocycle-aware methods; MD-based ring flexibility analysis

The service is built around conformational ensemble sampling. Depending on the molecule we may move to docking with macrocycle-aware methods or MD-based ring flexibility analysis to improve stability, loading or yield, and every batch is released with modeling report with binding hypotheses.

Because Cyclic Peptide Modeling projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Rationalizing cyclic SAR

Prioritizing analog synthesis

Modeling as a substitute for binding data

Cycles whose ring size is known to be geometrically uncloseable

Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.

Service Highlights

  • Conformational ensemble sampling as the default route, with docking with macrocycle-aware methods held as a proven fallback
  • MD-based ring flexibility analysis worked into the design where the application requires it
  • Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
  • Analytical confirmation of every intermediate before the final release
  • Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
  • Modeling report with binding hypotheses delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Precursor design

    Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Modeling ring size.

  2. Linear assembly

    The precursor chain is assembled with Fmoc chemistry and conformational ensemble sampling where relevant.

  3. Cyclization

    Ring closure is executed by docking with macrocycle-aware methods under screened dilution and activation conditions.

  4. Isomer separation

    RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.

  5. Characterization

    Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.

  6. Release

    Modeling report with binding hypotheses is documented and released after QC sign-off.

Specifications & timeline

Turnaround
2–5 weeks
Typical scale
1 – 200 mg cyclic peptide
Chemistry options
conformational ensemble sampling; docking with macrocycle-aware methods; MD-based ring flexibility analysis
Deliverable
Modeling report with binding hypotheses
QC package
HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
Shipping
Ambient with desiccant; blue ice for sensitive motifs

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.